UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acute, Short-Term And Long-Term Costs Of Cardiovascular Events Among Hyperlipidemia Patients

Value in health, 2015-05, Vol.18 (3), p.A138-A139

2015

Volltextzugriff (PDF)

Identification and management of canadian patients with symptoms of statin intolerance: Results from a real-world clinical practice survey

Atherosclerosis, 2016-09, Vol.252, p.e212-e212

2016

Volltextzugriff (PDF)

Costs Of Treating Cardiovascular Events In Germany: A Systematic Literature Review

Value in health, 2014-11, Vol.17 (7), p.A485-A485

2014

Volltextzugriff (PDF)

The efficacy of evolocumab and other lipid-lowering therapies (LLT) for the management of low density lipoprotein cholesterol (LDL-C): a systematic review and network meta-analysis (NMA)

Atherosclerosis, 2016-09, Vol.252, p.e56-e57

2016

Volltextzugriff (PDF)

Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United States

VALUE IN HEALTH, 2016, Vol.19 (3), p.A3-A3

2016

Volltextzugriff (PDF)

An Assessment Of The Current Literature On Apheresis Use In The Treatment Of Familial Hypercholesterolemia

Value in health, 2014-11, Vol.17 (7), p.A474-A474

2014

Volltextzugriff (PDF)

Long-Term Economic Burden Associated With Cardiovascular Events Among High-Risk Patients With Hyperlipidemia

Value in health, 2015-05, Vol.18 (3), p.A139-A140

2015

Volltextzugriff (PDF)

Deterministic Versus Stochastic Prediction of Risk for Cardiovascular Events

Value in health, 2014-11, Vol.17 (7), p.A558-A558

2014

Volltextzugriff (PDF)

PMS69 Tumor Necrosis Factor Blocker Dose Escalation among Biologic Naïve Rheumatoid Arthritis (RA) Patients in Commercial Managed Care Plans in the Two Years Following Therapy Initiation

Value in health, 2012-06, Vol.15 (4), p.A46-A46

2012

Volltextzugriff (PDF)

Health Care Costs Associated With Cardiovascular Events In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden

Value in health, 2014-11, Vol.17 (7), p.A492-A492

2014

Volltextzugriff (PDF)

Treatment Patterns in Hyperlipidemia Patients With New Cardiovascular Events - Estimates From Population-Based Register Data in Sweden

Value in health, 2014-11, Vol.17 (7), p.A501-A501

2014

Volltextzugriff (PDF)

Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in Sweden

Value in health, 2014-11, Vol.17 (7), p.A327-A328

2014

Volltextzugriff (PDF)

Burden Of Hyperlipidemia Resulting From Productivity Loss - Estimates From Population-Based Register Data In Sweden

Value in health, 2014-11, Vol.17 (7), p.A491-A492

2014

Volltextzugriff (PDF)

Ldl-C Goal Attainment In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden

Value in health, 2014-11, Vol.17 (7), p.A497-A497

2014

Volltextzugriff (PDF)

An Assessment of the Use of Utility Data in Long-Term Cost-Effectiveness Models of Lipid Lowering Therapies

Value in health, 2013-11, Vol.16 (7), p.A581-A581

2013

Volltextzugriff (PDF)

Patient-Level Costs of Cardiovascular Events and Procedures: How Robust Is the Evidence?

Value in health, 2013-11, Vol.16 (7), p.A522-A522

2013

Volltextzugriff (PDF)

Acute And Chronic Impact Of Cardiovascular Events On Health State Utilities

Value in health, 2014-11, Vol.17 (7), p.A493-A493

2014

Volltextzugriff (PDF)

PMS23 Cost Per Treated Rheumatoid Arthritis (RA) Patient for Etanercept, Adalimumab and Infliximab: A Retrospective Claims Database Analysis

Value in health, 2012-06, Vol.15 (4), p.A37-A37

2012

Volltextzugriff (PDF)

PMS16 Cost of Tumor Necrosis Factor Blocker Per Treated Psoriatic Arthritis Patient Using Drug Utilization Data from a US Managed Care Population

Value in health, 2012-06, Vol.15 (4), p.A36-A36

2012

Volltextzugriff (PDF)

PMS70 Tumor Necrosis Factor (TNF)-Blocker Dose Escalation among Patients with Rheumatoid Arthritis (RA) in a Large Managed Care Population in the United States

Value in health, 2012-06, Vol.15 (4), p.A46-A46

2012

Volltextzugriff (PDF)

Impact on Health-Related Quality of Life in Kidney Transplant Recipients with Late Posttransplant Anemia Administered Darbepoetin Alfa: Results from the STRATA Study

Transplantation proceedings, 2011-06, Vol.43 (5), p.1593-1600

2011

Volltextzugriff (PDF)

Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries

Osteoporosis international, 2022-02, Vol.33 (2), p.413-423

2022

Volltextzugriff (PDF)

Treatment patterns and long-term persistence with osteoporosis therapies in women with Medicare fee-for-service (FFS) coverage

Osteoporosis international, 2021-12, Vol.32 (12), p.2473-2484

2021

Volltextzugriff (PDF)

PMS14 Cost of Etanercept, Adalimumab, and Infliximab Per Treated Patient Across Adult Indications Using Real-World Data

Value in health, 2011, Vol.14 (7), p.A304-A304

2011

Volltextzugriff (PDF)

PMS46 IMPACT OF ETANERCEPT ON WORK AND ACTIVITY IMPAIRMENT IN EMPLOYED PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS

Value in health, 2011, Vol.14 (3), p.A131-A131

2011

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acute, Short-Term And Long-Term Costs Of Cardiovascular Events Among Hyperlipidemia Patients

Identification and management of canadian patients with symptoms of statin intolerance: Results from a real-world clinical practice survey

Costs Of Treating Cardiovascular Events In Germany: A Systematic Literature Review

The efficacy of evolocumab and other lipid-lowering therapies (LLT) for the management of low density lipoprotein cholesterol (LDL-C): a systematic review and network meta-analysis (NMA)

Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United States

An Assessment Of The Current Literature On Apheresis Use In The Treatment Of Familial Hypercholesterolemia

Long-Term Economic Burden Associated With Cardiovascular Events Among High-Risk Patients With Hyperlipidemia

Deterministic Versus Stochastic Prediction of Risk for Cardiovascular Events

PMS69 Tumor Necrosis Factor Blocker Dose Escalation among Biologic Naïve Rheumatoid Arthritis (RA) Patients in Commercial Managed Care Plans in the Two Years Following Therapy Initiation

Health Care Costs Associated With Cardiovascular Events In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden

Treatment Patterns in Hyperlipidemia Patients With New Cardiovascular Events - Estimates From Population-Based Register Data in Sweden

Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in Sweden

Burden Of Hyperlipidemia Resulting From Productivity Loss - Estimates From Population-Based Register Data In Sweden

Ldl-C Goal Attainment In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden

An Assessment of the Use of Utility Data in Long-Term Cost-Effectiveness Models of Lipid Lowering Therapies

Patient-Level Costs of Cardiovascular Events and Procedures: How Robust Is the Evidence?

Acute And Chronic Impact Of Cardiovascular Events On Health State Utilities

PMS23 Cost Per Treated Rheumatoid Arthritis (RA) Patient for Etanercept, Adalimumab and Infliximab: A Retrospective Claims Database Analysis

PMS16 Cost of Tumor Necrosis Factor Blocker Per Treated Psoriatic Arthritis Patient Using Drug Utilization Data from a US Managed Care Population

PMS70 Tumor Necrosis Factor (TNF)-Blocker Dose Escalation among Patients with Rheumatoid Arthritis (RA) in a Large Managed Care Population in the United States

Impact on Health-Related Quality of Life in Kidney Transplant Recipients with Late Posttransplant Anemia Administered Darbepoetin Alfa: Results from the STRATA Study

Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries

Treatment patterns and long-term persistence with osteoporosis therapies in women with Medicare fee-for-service (FFS) coverage

PMS14 Cost of Etanercept, Adalimumab, and Infliximab Per Treated Patient Across Adult Indications Using Real-World Data

PMS46 IMPACT OF ETANERCEPT ON WORK AND ACTIVITY IMPAIRMENT IN EMPLOYED PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS

Suchergebnisse filtern